Urinary incontinence, defined by the International Continence Society as “a condition in which involuntary loss of urine is a social or hygienic problem and is objectively demonstrable,” is largely seen in our society as a woman’s problem.
And the statistics support that perception. Urinary incontinence is more common in women than men by a 2-1 ratio. However, 18 percent of men are affected by incontinence sometime in their lifetime and should be not ignored.
The Biofeedback Certification Institute of America (BCIA) is currently investigating the creation of a separate, entry level, BCIA Certification in Pelvic Muscle Dysfunction (PMD). A multidisciplinary committee of pelvic muscle dysfunction experts was assembled with the task of formulating academic, professional, didactic, and supervision requirements for a PMD Certification. The committee was also asked to delineate requirements for the grandfathering of experienced clinicians in the field. BCIA would appreciate your reviewing the PMD materials posted on our website at BCIA.org and responding to our survey.
If you have come to this page looking for help with (IC) Interstitial Cystitis please visit the IC Help section of our site. Read the rest of this entry »
http://cms.hhs.gov/manuals/06_cim/ci35.asp#_35_271
35-27 BIOFEEDBACK THERAPY Biofeedback therapy provides visual, auditory or other evidence of the status of certain body functions so that a person can exert voluntary control over the functions, and thereby alleviate an abnormal bodily condition. Biofeedback therapy often uses electrical devices to transform bodily signals indicative of such functions as heart rate, blood pressure, skin temperature, salivation, peripheral vasomotor activity, and gross muscle tone into a tone or light, the loudness or brightness of which shows the extent of activity in the function being measured. Biofeedback therapy differs from electromyography, which is a diagnostic procedure used to record and study the electrical properties of skeletal muscle. An electromyography device may be used to provide feedback with certain types of biofeedback. Biofeedback therapy is covered under Medicare only when it is reasonable and necessary for the individual patient for muscle re-education of specific muscle groups or for treating pathological muscle abnormalities of spasticity, incapacitating muscle spasm, or weakness, and more conventional treatments (heat, cold, massage, exercise, support) have not been successful. This therapy is not covered for treatment of ordinary muscle tension states or for psychosomatic conditions. (See HCFA-Pub. 14-3, §§2200ff, 2215, and 4161; HCFA-Pub. 13-3, §§3133.3, 3148, and 3149; HCFA-Pub. 10, §§242 and 242.5 for special physical therapy requirements. See also §35-20 and 65-8.) Rev. 138 Read the rest of this entry »
Dr. Moldwin is Assistant Professor of Urology at the Albert Einstein College of Medicine and is Director of the Interstitial Cystitis Center at Long Island Jewish Medical Center (LIJMC) in New Hyde Park, NY. Dr. Moldwin completed his clinical training at the University of Chicago and his urological training at LIJMC. He then received a Valentine’s Fellowship award and pursued research investigations in IC at Thomas Jefferson Medical College. He subsequently returned to New York to establish the Interstitial Cystitis Center at LIJMC. Dr. Moldwin is active in both basic and clinical IC research and has published extensively. He is a frequent contributor to the ICA Update and has recently written and published a patient-oriented book entitled, The Interstitial Cystitis Survival Guide (New Harbinger Publications). Read the rest of this entry »
Introduction
Incontinence is a major healthcare problem costing a conservative estimate of $15 billion, annually, in the USA. This reality is mirrored in countries worldwide. Patients with this problem often lead lives of quiet desperation and social isolation.
Incontinence is among the leading causes of nursing home admission, with approximately 50% of all residents being incontinent. While it is estimated that the number of incontinent geriatric patients can be as high as 80%(11), it is more difficult to estimate the incidence in younger populations, though studies by Nygaard show incontinence to be common in young nulliparous women, particularly during physical activities. One Danish study(5), conducted with a group of 45-year-old women, found that 22% experienced stress incontinence. It was also noted that only three percent of these women sought medical attention for their problem. Read the rest of this entry »
A Randomized Controlled Trial
Kathryn L. Burgio, PhD; Julie L. Locher, MA; Patricia S. Goode, MD; J. Michael Hardin, PhD; B. Joan McDowell, PhD, CRNP; Marianne Dombrowski, DO; Dorothy Candib, MD
Context.—Urinary incontinence is a common condition caused by many factors with several treatment options.
Objective.—To compare the effectiveness of biofeedback-assisted behavioral treatment with drug treatment and a placebo control condition for the treatment of urge and mixed urinary incontinence in older community-dwelling women. Read the rest of this entry »
Founded in 1984, the Interstitial Cystitis Association (ICA) is a not-for-profit health organization dedicated to providing advocacy, research funding, and education to ensure optimal care with dignity for people affected by IC. The ICA works internationally on behalf of all IC patients: Read the rest of this entry »
Psychologists now have a more accurate, refined way of billing for services provided to patients with a physical health diagnosis, thanks to the advent of six new reimbursement codes under the Current Procedural Terminology (CPT) coding system.
As of January 1, 2002, codes for health and behavior assessment and intervention services now apply to behavioral, social, and psychophysiological procedures for the prevention, treatment or management of physical health problems. Developing these new codes involved the combined efforts of the APA’s Practice Directorate and the Interdivisional Healthcare Committee (IHC), representing APA divisions 17, 22, 38, 40 and 54. This constitutes a milestone in the recognition of psychologists as health care providers. Read the rest of this entry »
Listening and counseling patients are an important part of therapy, as well as biofeedback to coordinate their defecatory muscles during straining.
This article identifies and defines the various types of defecatory problems which make up idiopathic constipation. The main diagnostic tests for this condition are specified, and there is a discussion about the limited role that laxatives, fiber, and surgery play in the management of this condition. The authors suggests that the first line of treatment should be biofeedback and other non invasive treatments. The authors suggest that there is often significant psychological factors which contribute to this condition.
Storrie, JB. (1997). Biofeedback: a first-line of treatment for idiopathic constipation. British Journal of Nursing. 6(3): 152-8, FEB 13-26.
More than 15 million persons in the United States have urinary incontinence, [1] a condition more prevalent than diabetes mellitus. Urinary incontinence not only causes considerable medical and psychosocial morbidity but it also engenders enormous costs.
Conservative projections for costs related to diagnosis and treatment of urinary incontinence exceed $26 billion annually, [2] more than is expended by Medicare on dialysis (O. Cohen, oral communication, November 1998) and coronary bypass grafting combined. [3] Moreover, these costs apply only to individuals older than 65 years, who constitute less than half of those with urinary incontinence. Unfortunately, most physicians have received little education about incontinence, fail to screen for it, and view the likelihood of successful treatment as low. [3] Thus, it is fitting that the study by Burgio et al, which examines the efficacy of biofeedback for urge incontinence, should appear in JAMA. [4] Read the rest of this entry »
Products | Training | Blog | Network | Find a Therapist | Support | Contact Us Prices and specifications subject to change without notification. No warranty or claim is made About Us | International Orders | Terms & Conditions of Sale | Privacy Policy | Return Policy |
Bio-Medical Instruments, Inc. Toll Free: 800-521-4640 |
|
